Key Trends Shaping the Future Point-of-Care (POC) Coagulation Testing Market From 2025-2034: Increasing Focus On Innovative Products To Gain A Competitive Edge In The Market

How Are the key drivers contributing to the expansion of the point-of-care (poc) coagulation testing market?
The increasing prevalence of cardiovascular diseases is anticipated to boost the expansion of the point-of-care (POC) coagulation testing market in the future. This term refers to a range of issues impacting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation testing is beneficial in managing these conditions as it provides immediate coagulation status data, allowing for prompt decisions on coagulation interventions and minimizing the risk of bleeding issues after heart surgery. For example, a report from the World Heart Federation, a non-government organization based in Switzerland, published in October 2022, anticipates an expected rise in mortality from cardiovascular disease. The predicted number of deaths related to cardiovascular disease is expected to grow from around 18.9 million in 2020 to more than 22.2 million by 2030 and soar to 32.3 million by 2050. Hence, the growing prevalence of cardiovascular diseases is propelling the expansion of the point-of-care (POC) coagulation testing market.

Get Your Point-of-Care (POC) Coagulation Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

What growth opportunities are expected to drive the point-of-care (poc) coagulation testing market's CAGR through 2034?
The market size of point-of-care (POC) coagulation testing has experienced significant growth in the past few years. The market is projected to expand from $1.18 billion in 2024 to $1.25 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. The growth during the historical period can be credited to factors such as increased demand from patients, a rising trend in point-of-care testing, the high accuracy of coagulation status on pt test, automation, and integration with electronic health records (EHRs), and an increasing prevalence of cardiovascular diseases and blood disorders.

In the years to come, the point-of-care (POC) coagulation testing market is anticipated to witness consistent growth, reaching a market size of $1.48 billion in 2029 with a 4.2% compound annual growth rate (CAGR). This growth over the forecast period can be traced back to a broadening of applications in healthcare, increasing need in homecare scenarios, higher prevalence of long-lasting blood issues, patient requests for quick and precise tests, and a surge in point-of-care testing. The key trends in the forecast period are driven by technological improvements, strong demand in developed nations, a greater scope of applications in healthcare, the effects of COVID-19, and the multiplexing POC diagnostics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

What are the emerging trends shaping the future of the point-of-care (poc) coagulation testing market?
Major firms involved in the point-of-care (POC) coagulation testing market are focusing on strategic partnerships to gain a market advantage. A strategic partnership is a formal agreement between two or more entities to collaborate in achieving specific, mutually beneficial objectives. For example, in January 2023, Jana care, a US firm that develops biomarker assays for its proprietary digital health platform, entered into a partnership with Roche Diagnostics, a Swiss company known for developing diagnostic tests, equipment, and digital solutions with immense potential to revolutionize healthcare. Their joint efforts are aimed at creating and distributing a point-of-care blood testing platform specifically for chronic kidney disease and heart failure screening. This groundbreaking platform will allow patients to conduct blood tests at home, which will then be remotely analyzed by clinicians.

Which growth-oriented segments of the point-of-care (poc) coagulation testing market are leading the industry's development?
The point-of-care (POC) coagulation testing market covered in this report is segmented -

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care

Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913

What regions are leading the charge in the point-of-care (poc) coagulation testing market?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the point-of-care (poc) coagulation testing market?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp

What Is Covered In The Point-of-Care (POC) Coagulation Testing Global Market Report?

•Market Size Forecast: Examine the point-of-care (poc) coagulation testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the point-of-care (poc) coagulation testing market for a structured understanding.
•Key Players Overview: Analyze major players in the point-of-care (poc) coagulation testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the point-of-care (poc) coagulation testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the point-of-care (poc) coagulation testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the point-of-care (poc) coagulation testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the point-of-care (poc) coagulation testing market.
•Competitive Landscape: Review strategic developments in the point-of-care (poc) coagulation testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.